APPLICATION
ANDA090057
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-25
LATEST ACTION
2022-01-13
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CEFTRIAXONEPrescription
CEFTRIAXONE SODIUM EQ 100GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2022-01-13Labeling · Supplement 4 · standardAP
2016-05-12Labeling · Supplement 2 · standardAP
2014-04-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.